DEXCOM INC. news, videos and press releases - Page 4
For more news please use our advanced search feature.
DEXCOM INC. - More news...
DEXCOM INC. - More news...
- DXCM Notice of Investigation: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm
- DexCom Inc Securities Fraud Investigation By The Schall Law Firm Welcomes Investor Participation
- DXCM Investors Have Opportunity to Join DexCom, Inc. Securities Fraud Investigation with the Schall Law Firm
- DXCM Investors Have Opportunity to Join DexCom, Inc. Securities Fraud Investigation with the Schall Law Firm
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCM
- DXCM Investors Have Opportunity to Join DexCom, Inc. Securities Fraud Investigation with the Schall Law Firm
- DexCom Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm
- DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM
- DXCM Investors Have Opportunity to Join DexCom, Inc. Securities Fraud Investigation with the Schall Law Firm
- DXCM Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm
- Johnson Fistel Begins Investigation into DexCom Following a Significant Drop in the Company's Stock
- Edelson Lechtzin LLP Announces Investigation Dexcom, Inc. (NASDAQ: DXCM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
- Bio Conscious Announces Strategic API Integration with Dexcom That Will Elevate the Current Level of Care for Diabetes Patients in Clinical Settings
- Beta Bionics Announces the Nationwide Launch of the iLet Bionic Pancreas With Dexcom G7 CGM System
- Thinking about buying stock in Bitfarms, Mullen Automotive, SeaStar Medical Holding, NKGen Biotech, or DexCom?
- Dexcom Canada Achieves Great Place to Work® Certification for Second Consecutive Year
- Dexcom Reports Second Quarter 2023 Financial Results
- Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4:30 p.m. Eastern Time
- Dexcom G7 Receives Health Canada Approval: Next-Generation Continuous Glucose Monitoring System With Unmatched Accuracy Coming to Canadians
- Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More
- Dexcom Updates Long-Range Financial Targets
- Dexcom G6 Strengthens Its Position as World’s Most Connected CGM System
- New Study Shows That 84% of People With Diabetes Struggle With Mental Health1
- Dexcom to Host Investor Day on June 23, 2023
- Dexcom Announces Upcoming Conference Presentation
-
How Dexcom And Abbott Are Moving Beyond Diabetes
- Dexcom Showcases Accuracy, Reliability and Ease of Use of Its Dexcom G6 CGM System at the 66th Annual Meeting of the Japan Diabetes Society
- Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028
- Dexcom rtCGM is Likely to be Cost-Saving, Study Suggests
- Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes
